Cellgenix RH TPO - GMP and preclinical grade, and GMP FLT-3L, 50 UG.
Ended Purchase Order Awarded Last action
- Contract number
- 75N90020P00631
- Awardee
-
Cellgenix USA UEI CCYHJN1KNAM6
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $11,943
Award facts
- Contract value 100% obligated
- $11,942.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Portsmouth, NH 03801, USA
Award details come from SAM.gov/FPDS.
About this award
The NIH Clinical Center awarded a purchase order to Cellgenix USA for $11,942.50 on August 4, 2020, for CellGenix RH TPO GMP and preclinical grade materials and GMP FLT-3L (50 micrograms). The order is firm fixed price with no set-aside designation. Work is performed in Portsmouth, New Hampshire, with an ultimate completion date of August 11, 2020.
Quick answers
Who was awarded contract 75N90020P00631?
75N90020P00631 was awarded to Cellgenix USA by NIH Clinical Center (National Institutes of Health) on August 4, 2020.
How much is contract 75N90020P00631 worth?
The government has obligated $11,943 on 75N90020P00631.
Was contract 75N90020P00631 competed?
The extent of competition for 75N90020P00631 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award